Boheng Zhang
- Hepatology top 0.2%
- Epidemiology top 2%
- Oncology top 2%
- Cancer Research top 2%
- Molecular Biology top 10%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (38 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers)Liver Disease Diagnosis and Treatment (17 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Boheng Zhang
81 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Hepatology 2.2k
- Epidemiology 1.6k
- Oncology 1.1k
- Cancer Research 1.0k
- Molecular Biology 982
Countries citing papers authored by Boheng Zhang
This map shows the geographic impact of Boheng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boheng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boheng Zhang more than expected).
Fields of papers citing papers by Boheng Zhang
This network shows the impact of papers produced by Boheng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boheng Zhang. The network helps show where Boheng Zhang may publish in the future.
Co-authorship network of co-authors of Boheng Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Boheng Zhang. A scholar is included among the top collaborators of Boheng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boheng Zhang. Boheng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 8 | |
| 4 | 1 | |
| 5 | 66 | |
| 6 | 5 | |
| 7 | 91 | |
| 8 | 28 | |
| 9 | 33 | |
| 10 | 44 | |
| 11 | 25 | |
| 12 | 1 | |
| 13 | 42 | |
| 14 | 83 | |
| 15 | A survey of content and form of evidence-based nursing education in Shanghai | 1 |
| 16 | 129 | |
| 17 | 86 | |
| 18 | 151 | |
| 19 | 72 | |
| 20 | Randomized controlled trial of screening for hepatocellular carcinomabreakdown → | 1049 |
About Boheng Zhang
Boheng Zhang is a scholar working on Hepatology, Cancer Research and Pathology and Forensic Medicine, having authored 83 papers that have together received 4.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (38 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers) and Liver Disease Diagnosis and Treatment (17 papers). The work is most often cited by research in Hepatology (2.2k citations), Cancer Research (1.0k citations) and Epidemiology (1.6k citations). Boheng Zhang has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Zhao–You Tang, Bing‐Hui Yang, Xin Yin, Zhenggang Ren, Shuang–Jian Qiu, Jia Fan, Lan Zhang, Su-Su Zheng, Sheng‐Long Ye and Tong‐Chun Xue. Their work appears in journals such as Journal of Clinical Oncology, Bioinformatics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.